Obesity remains a pressing public health challenge in North America, with rates steadily climbing and driving the demand for innovative and effective anti-obesity treatments. According to projections, the North American anti-obesity drugs market is set to grow at an impressive compound annual growth rate (CAGR) of 9.30% from 2024 to 2032. This growth is attributed to a...